What Medication-Assisted Treatment Actually Does

Medication-Assisted Treatment (MAT) combines FDA-approved medication with counseling and behavioral therapy to treat substance use disorders, and for opioid use disorder specifically, it’s considered the gold-standard approach by major medical organizations. The medication isn’t a replacement for therapy — it’s what makes therapy possible. By easing withdrawal symptoms and cravings, MAT gives your brain and body room to stabilize so the emotional and behavioral work of recovery can actually take hold.

How Suboxone Works

Suboxone is a combination of buprenorphine and naloxone. Buprenorphine is a partial opioid agonist, meaning it activates opioid receptors in the brain just enough to relieve cravings and withdrawal symptoms, without producing the intense high of full opioids like heroin or fentanyl. It’s taken daily, usually as a dissolving film or tablet, and dosing is adjusted by your care team based on how you respond. One of the biggest practical advantages of Suboxone is that you don’t need to complete a full detox before starting — treatment can often begin while you’re still in mild withdrawal, which lowers the barrier to getting started.

How Vivitrol Works

Vivitrol is an extended-release, once-monthly injectable form of naltrexone. Unlike Suboxone, naltrexone is an opioid antagonist — it blocks opioid receptors entirely rather than activating them, so if someone were to use opioids while on Vivitrol, they wouldn’t feel the effects. The tradeoff is timing: because Vivitrol is a full blocker, you have to be completely opioid-free before your first dose, typically at least 7 to 10 days abstinent with a negative toxicology screen, and often a naloxone challenge to confirm your system is clear. For people who’ve already completed detox, the once-a-month schedule and the absence of any daily medication can be a major appeal.

What the Research Shows

Both medications are effective, but clinical research highlights some real differences in how they perform, especially in outpatient settings. A widely cited six-month trial comparing the two found that participants on Suboxone had a lower relapse rate (57%) than those on Vivitrol (65%), and averaged more than double the number of opioid-free days (81 days versus 39). Suboxone also had a notably higher successful treatment start rate — 94% compared to 72% for Vivitrol — largely because Vivitrol’s detox requirement is a hard barrier for some patients to clear on an outpatient basis. On the mortality side, national research has found that people treated with buprenorphine were 38% less likely to die of an opioid overdose during treatment compared to those who received no medication at all, underscoring just how protective these medications can be when someone stays engaged in care.

Questions to Discuss With Your Treatment Team

Which One Might Be Right for You?

There isn’t a universal “better” choice between Suboxone and Vivitrol — there’s only the option that fits your body, your history, and your life right now. Some people start with one medication and switch to the other as their circumstances change, and that’s completely normal. What matters most is working with a treatment team that knows your full history, monitors how you’re responding, and adjusts the plan as needed rather than locking you into a single path on day one.

You Don’t Have to Figure This Out Alone

At Miami Valley Recovery, our team offers both Suboxone and Vivitrol as part of individualized Medication Assisted Treatment plans, paired with medication management, toxicology screening, nursing support, and individual and group therapy — all in an outpatient setting designed to fit real life. If you’re weighing your options or ready to take the next step, visit us at miamivalleyrecovery.com or call us at 937-401-8672 to talk with someone who understands what you’re going through. Recovery looks different for everyone, and the right medication is simply the one that helps you get there.